ELI LILLY AND COMPANY Accrued Income Taxes, Noncurrent
ELI LILLY AND COMPANY (LLY) had Accrued Income Taxes, Noncurrent of $5.46 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:AccruedIncomeTaxesNoncurrent · last filed 2026-08-05
- 2026-06-30: Accrued Income Taxes, Noncurrent $5.46B.
- 2026-03-31: Accrued Income Taxes, Noncurrent $5.29B.
- 2025-12-31: Accrued Income Taxes, Noncurrent $5.88B.
- 2025-09-30: Accrued Income Taxes, Noncurrent $6.29B.
| Period end | Accrued Income Taxes, Noncurrent | Accrued Income Taxes, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $5.46B 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $5.29B 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $5.88B 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $6.29B 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $5.68B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $5.37B 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $4.06B 10-K · filed 2026-02-12 | $4.06B 10-K · filed 2025-02-19 |
| 2024-09-30 | $3.88B 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $3.50B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $4.19B 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $3.85B 10-K · filed 2025-02-19 | |
| 2023-09-30 | $3.47B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $3.33B 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $3.84B 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $3.71B 10-K · filed 2024-02-21 | |
| 2022-09-30 | $3.64B 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $3.56B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $3.98B 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $3.92B 10-K · filed 2023-02-22 | |
| 2021-09-30 | $3.77B 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $3.74B 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $3.92B 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $3.84B 10-K · filed 2022-02-23 | |
| 2020-09-30 | $3.39B 10-Q · filed 2020-10-28 | |
| 2020-06-30 | $3.38B 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $3.62B 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $3.61B 10-K · filed 2021-02-17 | |
| 2019-09-30 | $3.53B 10-Q · filed 2019-10-25 | |
| 2019-06-30 | $3.49B 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $3.76B 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $3.70B 10-K · filed 2020-02-19 | $3.72B 10-K · filed 2019-02-19 |
| 2018-09-30 | $3.74B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $3.51B 10-Q · filed 2018-07-25 | |
| 2018-03-31 | $3.75B 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $3.75B 8-K · filed 2019-10-24 | $3.78B 10-K · filed 2018-02-20 |
| 2017-09-30 | $710.00M 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $705.00M 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $697.20M 10-Q · filed 2017-05-01 | |
| 2016-12-31 | $688.90M 10-K · filed 2018-02-20 | |
| 2016-09-30 | $805.60M 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $805.10M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $908.00M 10-Q · filed 2016-04-29 | |
| 2015-12-31 | $868.90M 10-K · filed 2017-02-21 | |
| 2015-09-30 | $910.60M 10-Q · filed 2015-10-30 | |
| 2015-06-30 | $1.03B 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $954.00M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $998.50M 10-K · filed 2016-02-19 | |
| 2014-09-30 | $932.80M 10-Q · filed 2014-10-29 | |
| 2014-06-30 | $940.10M 10-Q · filed 2014-07-28 | |
| 2014-03-31 | $906.60M 10-Q · filed 2014-04-28 | |
| 2013-12-31 | $1.08B 10-K · filed 2015-02-19 | |
| 2013-09-30 | $853.50M 10-Q · filed 2013-10-30 | |
| 2013-06-30 | $1.41B 10-Q · filed 2013-07-26 | |
| 2013-03-31 | $1.36B 10-Q · filed 2013-04-26 | |
| 2012-12-31 | $1.33B 10-K · filed 2014-02-19 | |
| 2012-09-30 | $1.28B 10-Q · filed 2012-10-26 | |
| 2012-06-30 | $1.21B 10-Q · filed 2012-07-27 | |
| 2012-03-31 | $1.16B 10-Q · filed 2012-04-30 | |
| 2011-12-31 | $1.09B 10-K · filed 2013-02-21 | |
| 2011-09-30 | $1.06B 10-Q · filed 2011-10-28 | |
| 2011-06-30 | $1.28B 10-Q · filed 2011-07-29 | |
| 2011-03-31 | $1.22B 10-Q · filed 2011-04-29 | |
| 2010-12-31 | $1.23B 10-K · filed 2012-02-24 | |
| 2010-09-30 | $1.30B 10-Q · filed 2010-10-29 | |
| 2010-06-30 | $1.23B 10-Q/A · filed 2010-08-02 | |
| 2010-03-31 | $1.14B 10-Q · filed 2010-07-30 | |
| 2009-12-31 | $1.09B 10-K · filed 2011-02-22 | |
| 2009-09-30 | $990.00M 10-Q · filed 2009-10-30 | |
| 2009-06-30 | $969.60M 10-Q · filed 2009-07-31 | |
| 2008-12-31 | $906.20M 10-K · filed 2010-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |